Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (151-160 of 319) with videos related to

Pageof 32
Sort By:
The AAPS Journal|April 6, 2006
N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomesLincoln H Wilkins, Dennis K Miller, Joshua T Ayers, et al.
Journal of Chemical Biology|October 5, 2016
Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studiesS Vijaya Laxmi, P Anil, G Rajitha, et al.
Cancer Research|March 18, 2010
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cellsYulan Sun, Daret K St Clair, Yong Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine releaseZhenfa Zhang, Guangrong Zheng, Marharyta Pivavarchyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptorsLincoln H Wilkins, Vladimir P Grinevich, Joshua T Ayers, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2008
Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine releaseZhenfa Zhang, Guangrong Zheng, Marharyta Pivavarchyk, et al.
Journal of Medicinal Chemistry|December 22, 2006
Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactionsXiaoqin Huang, Fang Zheng, Xi Chen, et al.
Pharmacology, Biochemistry, and Behavior|September 26, 2009
Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotineAmanda M Struthers, Jamie L Wilkinson, Linda P Dwoskin, et al.
BMC Cancer|April 18, 2013
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancerMichele T Yip-Schneider, Huangbing Wu, Keith Stantz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 17, 2008
Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptorFang Zheng, Guangrong Zheng, A Gabriela Deaciuc, et al.
Pageof 32

Showing results (151-160 of 319) with videos related to

Sort By:
Pageof 32
The AAPS Journal|April 6, 2006
N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomesLincoln H Wilkins, Dennis K Miller, Joshua T Ayers, et al.
Journal of Chemical Biology|October 5, 2016
Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studiesS Vijaya Laxmi, P Anil, G Rajitha, et al.
Cancer Research|March 18, 2010
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cellsYulan Sun, Daret K St Clair, Yong Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel bis-, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine releaseZhenfa Zhang, Guangrong Zheng, Marharyta Pivavarchyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptorsLincoln H Wilkins, Vladimir P Grinevich, Joshua T Ayers, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2008
Tetrakis-azaaromatic quaternary ammonium salts: novel subtype-selective antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine releaseZhenfa Zhang, Guangrong Zheng, Marharyta Pivavarchyk, et al.
Journal of Medicinal Chemistry|December 22, 2006
Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactionsXiaoqin Huang, Fang Zheng, Xi Chen, et al.
Pharmacology, Biochemistry, and Behavior|September 26, 2009
Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotineAmanda M Struthers, Jamie L Wilkinson, Linda P Dwoskin, et al.
BMC Cancer|April 18, 2013
Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancerMichele T Yip-Schneider, Huangbing Wu, Keith Stantz, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 17, 2008
Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptorFang Zheng, Guangrong Zheng, A Gabriela Deaciuc, et al.
Pageof 32